BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 22, 2008
View Archived Issues
Hedgehog pathway inhibitor shows potential benefits in cancer models
Read More
LRG-47: a novel therapeutic target in multiple sclerosis
Read More
Low relapse rate and MRI activity in MS with oral FTY-720 in 30-month extension study
Read More
Lumiliximab activity is independent of antigen expression levels in lymphocytic leukemia cells
Read More
Nippon Shinyaku receives approval for dysmenorrhea agent in Japan
Read More
ABT-263 improves oral bioavailability and potency of Bcl-2 family protein inhibitors
Read More
Schering-Plough receives Japanese approval for Aroglycem
Read More
ARRY-520 enters phase I/II clinical evaluation
Read More
JAK2 inhibitor INCB-18424 to be evaluated in phase II studies
Read More
Boston Scientific receives Canadian approval for sale of Taxus Liberte coronary stent
Read More
BrainCells initiates phase II clinical trial of BCI-540 for depression with anxiety
Read More
Novel antithrombotic agents disclosed in recent Portola patent
Read More
Recent Schering patents divulge new analgesic agents
Read More
Romark initiates enrollment in phase II clinical trial of Alinia in hepatitis C
Read More
Preclinical activity of Aurora kinase B/C inhibitor GSK-1070916A described
Read More
CD-200-Fc significantly improves arthritis in mouse model
Read More
Alseres opens seven enrollment sites for first stage of Altropane phase III clinical trial program
Read More
Innocoll initiates dosing in phase II clinical trial of CollaRx gentamicin topical sponge
Read More
CSL Behring submits NDS to Health Canada for approval of C1-esterase inhibitor for HAE
Read More
Raptor initiates phase IIa Convivia study in subjects with ALDH2 deficiency
Read More
Thalidomide Pharmion granted E.U. marketing authorization for multiple myeloma
Read More
Recent Speedel patent reports novel antihypertensive agents
Read More
Sutent approved in Japan for GIST and renal cell carcinoma
Read More
Champix set for Japanese launch
Read More
Bayer launches Nexavar in Japan for recurrent renal carcinoma
Read More